3-(4,5-Diphenyloxazol-2-yl)propanoic acid

Catalog No. :
ACZKCV096
CAS No. :
21256-18-8
Molecular Formula :
C18H15NO3
Molecular Weight :
293.32

IUPAC Name:3-(4,5-diphenyloxazol-2-yl)propanoic acid

3-(4,5-Diphenyloxazol-2-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g99%$74.00Login to see priceIn stockInquiry
500g99%$259.00Login to see priceIn stockInquiry
1000g99%$413.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4,5-Diphenyloxazol-2-yl)propanoic acid
IUPAC Name3-(4,5-diphenyloxazol-2-yl)propanoic acid
MDL No.MFCD00215977
Molecular FormulaC18H15NO3
Molecular Weight293.32
SMILESO=C(O)CCC1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)O1
InChI KeyOFPXSFXSNFPTHF-UHFFFAOYSA-N
Synonymoxaprozin | 21256-18-8 | Daypro | 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid | Alvo | 3-(4,5-Diphenyloxazol-2-yl)propanoic acid | Oxaprozinum | Oxaprozine | Deflam | Voir | Oxaprozina | 4,5-Diphenyl-2-oxazolepropionic acid | WY-21743 | 4,5-Diphenyl-2-oxazolepropanoic acid | WY-2
CAS No.21256-18-8
PubChem CID4614

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACZKCV096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACABCJ598 route compound structure diagram
    ACABCJ59852193-54-1 In Stock
  6. Then
  7. ACZKCV096 route product structure diagram
    ACZKCV09621256-18-8 In Stock
Inquiry

2. ACZKCV096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZKCV096 route product structure diagram
    ACZKCV09621256-18-8 In Stock
Inquiry

Comments (0)